Alchemia Limited (Alchemia)

Oncology Corporate Profile

HQ Location

PO Box 4851, Eight Mile Plains
Brisbane, Australia, Qld 4113

Company Description

Alchemia Limited is a listed Australian biopharmaceutical company (ASX:ACL) with an FDA approved drug (Fondaparinux sodium) and a late stage oncology product pipeline derived from the HyACT platform. In addition, Alchemia has a proprietary drug discovery platform, VAST®, derived from Alchemia's chemistry expertise.


This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
irinotecantopoisomerase I inhibitorColorectal cancerIII
irinotecantopoisomerase I inhibitorSmall Cell Lung Cancer (SCLC)II


Recent News Headlines

There are no news items to display